Example: Heart Attack

Search clinical trials for: Immune Sera

Total 106 results

NCT00002036

Completed

Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

Conditions: HIV Infections
NCT00000751

Completed

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

Conditions: HIV Infections; Pregnancy
NCT00000827

Completed

A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children

Conditions: HIV Infections
NCT00000961

Terminated

The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants

Conditions: HIV Infections
NCT04618783

Completed

Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization

Conditions: Poliomyelitis
NCT01078857

Unknown status

Small-fiber Neuropathy in Chronic Kidney Disease

Conditions: Small-Fiber Neuropathy; Chronic Kidney Disease
NCT02999815

Completed

Intrathecal Tetanus Immunoglobulin to Treat Tetanus

Conditions: Tetanus
NCT03018366

Recruiting

Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

Conditions: Estrogen Deficiency; Cardiovascular Disease (CVD); Hypothalamic Amenorrhea
NCT01368224

Completed

Two Supplemented Against Skin Reactivity

Conditions: Skin Sensitivity; Trans-epidermal Water Loss; Clinical Score; Assessment of Skin Moisturization Factors; Assessment of Serum Immune-regulatory Cytokine; Evaluation of Intestinal Flora Composition
NCT04510012

Recruiting

Characterizing the Immune Response and Neuronal Damage in COVID-19

Conditions: SARS-CoV Infection; Covid-19
NCT03044353

Terminated

Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698

Conditions: Amyloidosis
NCT00185692

Completed

Allogeneic Transplantation From Related Haploidentical Donors

Conditions: Blood Cancer; Leukemia; Graft Versus Host Disease; Malignancy; CLL; NHL; Hodgkin's Disease; MDS
NCT04189679

Recruiting

Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

Conditions: Non Small Cell Lung Cancer
NCT04005677

Recruiting

The Early Diagnosis of Pulmonary Nodule Based on Multi-dimension Messages

Conditions: Pulmonary Nodule, Solitary; Lung; Node
NCT03899428

Recruiting

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

Conditions: Hepatocellular Carcinoma
NCT01563627

Completed

Serum Profile of Inflammatory Factors, Immune and Angiogenic in Temporal Lobe Epilepsy

Conditions: Epilepsy
NCT02415842

Completed

A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

Conditions: Immunologic Tests
NCT02425241

Completed

Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination

Conditions: HIV
NCT03711214

Recruiting

Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome

Conditions: Sjogren's Syndrome
NCT00448253

Completed

Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum

Conditions: Symptoms of Inhalational Anthrax
NCT04361734

Recruiting

The Role of Lipids in Immune Cell Function in SLE Patients

Conditions: Lupus Erythematosus, Systemic
NCT03984318

Recruiting

Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs

Conditions: Cancer
NCT04324411

Not yet recruiting

Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia

Conditions: Autoimmune Anemia
NCT03713606

Unknown status

Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802)

Conditions: Hypertension, Portal
NCT01946750

Completed

Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections

Conditions: Clostridium Difficile Infection